Ubiquitin ligase CHIP suppresses cancer stem cell properties in a population of breast cancer cells

被引:20
作者
Tsuchiya, Mai [1 ]
Nakajima, Yuka [1 ,2 ]
Hirata, Naoya [3 ]
Morishita, Tamaki [1 ]
Kishimoto, Hiroyuki [1 ,2 ]
Kanda, Yasunari [3 ]
Kimura, Keiji [1 ]
机构
[1] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan
[2] Univ Tsukuba, Life Sci Ctr, Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan
[3] Natl Inst Hlth Sci, Div Pharmacol, Setagaya Ku, Tokyo 1588501, Japan
关键词
CHIP; Cancer stem cell; Breast cancer; SIDE POPULATION; PROTEIN; IDENTIFICATION; DEGRADATION; CHAPERONE; TUMORS; RESISTANCE;
D O I
10.1016/j.bbrc.2014.09.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cancer stem cells (CSCs) have several distinctive characteristics, including high metastatic potential, tumor-initiating potential, and properties that resemble normal stem cells such as self-renewal, differentiation, and drug efflux. Because of these characteristics, CSC is regarded to be responsible for cancer progression and patient prognosis. In our previous study, we showed that a ubiquitin E3 ligase carboxyl terminus of Hsc70-interacting protein (CHIP) suppressed breast cancer malignancy. Moreover, a recent clinical study reported that CHIP expression levels were associated with favorable prognostic parameters of patients with breast cancer. Here we show that CHIP suppresses CSC properties in a population of breast cancer cells. CHIP depletion resulted in an increased proportion of CSCs among breast cancers when using several assays to assess CSC properties. From our results, we propose that inhibition of CSC properties may be one of the functions of CHIP as a suppressor of cancer progression. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:928 / 932
页数:5
相关论文
共 37 条
  • [1] A differential role for CXCR4 in the regulation of normal versus malignant breast stem cell activity
    Ablett, Matthew P.
    O'Brien, Ciara S.
    Sims, Andrew H.
    Farnie, Gillian
    Clarke, Robert B.
    [J]. ONCOTARGET, 2014, 5 (03) : 599 - 612
  • [2] Prospective identification of tumorigenic breast cancer cells
    Al-Hajj, M
    Wicha, MS
    Benito-Hernandez, A
    Morrison, SJ
    Clarke, MF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) : 3983 - 3988
  • [3] Self-renewal and solid tumor stem cells
    Al-Hajj, M
    Clarke, MF
    [J]. ONCOGENE, 2004, 23 (43) : 7274 - 7282
  • [4] Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype
    Balic, Marija
    Lin, Henry
    Young, Lillian
    Hawes, Debra
    Giuliano, Armando
    McNamara, George
    Datar, Ram H.
    Cote, Richard J.
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (19) : 5615 - 5621
  • [5] Ballinger CA, 1999, MOL CELL BIOL, V19, P4535
  • [6] Alpha-6 integrin is necessary for the tumourigenicity of a stem cell-like subpopulation within the MCF7 breast cancer cell line
    Cariati, Massimiliano
    Naderi, Ali
    Brown, John P.
    Smalley, Matthew J.
    Pinder, Sarah E.
    Caldas, Carlos
    Purushotham, Anand D.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (02) : 298 - 304
  • [7] How powerful is CD133 as a cancer stem cell marker in brain tumors?
    Cheng, Jin-Xiang
    Liu, Bo-Lin
    Zhang, Xiang
    [J]. CANCER TREATMENT REVIEWS, 2009, 35 (05) : 403 - 408
  • [8] Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties
    Chiba, Tetsuhiro
    Kita, Kaoru
    Zheng, Yun-Wen
    Yokosuka, Osamu
    Saisho, Hiromitsu
    Iwama, Atsushi
    Nakauchi, Hiromitsu
    Taniguchi, Hideki
    [J]. HEPATOLOGY, 2006, 44 (01) : 240 - 251
  • [9] Cancer heterogeneity-a multifaceted view
    De Sousa E Melo, Felipe
    Vermeulen, Louis
    Fessler, Evelyn
    Medema, Jan Paul
    [J]. EMBO REPORTS, 2013, 14 (08) : 686 - 695
  • [10] ABC Transporters, Drug Resistance, and Cancer Stem Cells
    Dean, Michael
    [J]. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2009, 14 (01) : 3 - 9